Sign up to save your podcasts
Or
Share Today’s Clinical Trials Define the Next Era in Myeloma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Today’s Clinical Trials Define the Next Era in Myeloma
In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for multiple myeloma. From optimizing selinexor use, to understanding long-term MonumenTAL-1 data with talquetamab, to the promise of emerging trispecific antibodies, Dr. Mian highlights the biggest shifts shaping care today.
View all episodes
By Rahul Banerjee, MD
4.8
2626 ratings
In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for multiple myeloma. From optimizing selinexor use, to understanding long-term MonumenTAL-1 data with talquetamab, to the promise of emerging trispecific antibodies, Dr. Mian highlights the biggest shifts shaping care today.
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
138 Listeners
Research To Practice | Oncology Videos
116 Listeners
Making Sense with Sam Harris
26,355 Listeners
The Hematologist
28 Listeners
OncoPharm
184 Listeners
VJHemOnc Podcast
2 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Blood Podcast
54 Listeners
The Curious Clinicians
372 Listeners
Healthcare Unfiltered
136 Listeners
ASTCT Talks
9 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
185 Listeners
Blood Cancer Talks
49 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners